{"id":263090,"date":"2026-09-23T09:59:47","date_gmt":"2026-09-23T04:29:47","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=263090"},"modified":"2026-09-23T09:59:47","modified_gmt":"2026-09-23T04:29:47","slug":"alpa-laboratories-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/alpa-laboratories-best-stock-in-its-sector\/","title":{"rendered":"Is Alpa Laboratories the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Alpa Laboratories CMP Rs 61 (23 Sep 2026). Market cap Rs 128 Cr. ROE 8.06%. P\/E 31.43x versus Industry P\/E 38.56x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Alpa Laboratories is one of the names investors compare when screening the Healthcare sector, built on a 8.06% return on equity and a P\/E of 31.43x against an Industry P\/E of 38.56x. Whether Alpa Laboratories is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Alpa Laboratories<\/a> the best stock in its sector? The stock trades on the NSE at Rs 61 as of 23 September 2026, within its 52-week range of Rs 46.10 to Rs 95.00. Alpa Laboratories Ltd manufactures pharmaceutical formulations, primarily tablets and capsules, for domestic institutional and export customers.<\/p>\n

Alpa Laboratories sits in the Healthcare sector, and its 8.06% ROE and 31.43x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n